In the austere quiet of a Delaware courtroom, a financial paradox has unfolded that defies the standard laws of corporate insolvency. Apple Tree Partners, a venture capital titan managing assets estimated between $1 billion (approximately KES 130 billion) and $10 billion (approximately KES 1.3 trillion), filed for voluntary Chapter 11 bankruptcy late last year. The trigger for this maneuver was not a catastrophic market collapse, a sudden regulatory shutdown, or a failure of the drug pipeline it supports. Instead, the legal filings cited liabilities of less than $500,000 (approximately KES 65 million)—a sum that barely covers the annual operating budget of a modest mid-sized laboratory.
This filing, which continues to ripple through…